You can buy or sell XERS and other stocks, options, ETFs, and crypto commission-free!
Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol™ and XeriJect™ formulation technologies. Read More The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Xeris Pharmaceuticals Announces First Quarter 2019 Financial Results and Highlights Its Pipeline
Markets InsiderApr 26
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHICAGO, April 26, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that on April 24, 2019, the Compensation Committee of Xeris’ Board of Directors granted non-qualified stock options for an aggregate of 73,000 shares of its common stock to eight new employees under Xeris’ Inducement Equity Plan. Xeris’ Induc...
Expected Aug 12, After Hours